{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:59:18Z","timestamp":1780631958219,"version":"3.54.1"},"reference-count":28,"publisher":"Europa Digital & Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.4244\/eijv9i4a71","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T09:36:30Z","timestamp":1380015390000},"page":"430-436","source":"Crossref","is-referenced-by-count":18,"title":["One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial"],"prefix":"10.4244","volume":"9","author":[{"given":"Stefanie","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Ferenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Massberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin A.","family":"Birkmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kufner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dommasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Sch\u00fchlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sch\u00f6mig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-201392481643-0","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction.","volume":"362","author":"Yeh RW.","year":"2010","journal-title":"N Engl J Med."},{"key":"key-201392481643-1","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (\u201ccooling-off\u201d strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.","volume":"290","author":"Neumann FJ.","year":"2003","journal-title":"JAMA."},{"key":"key-201392481643-2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/eurheartj\/ehq276","article-title":"Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes.","volume":"32","author":"Katritsis DG.","year":"2011","journal-title":"Eur Heart J."},{"key":"key-201392481643-3","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.","volume":"365","author":"Kastrati A.","year":"2011","journal-title":"N Engl J Med."},{"key":"key-201392481643-4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.","volume":"51","author":"Ndrepepa G.","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-201392481643-5","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1161\/01.CIR.0000148956.93631.4D","article-title":"Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.","volume":"110","author":"Mehilli J.","year":"2004","journal-title":"Circulation."},{"key":"key-201392481643-6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.amjcard.2007.12.019","article-title":"Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.","volume":"101","author":"Iijima R.","year":"2008","journal-title":"Am J Cardiol."},{"key":"key-201392481643-7","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-201392481643-8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch P.","year":"1994","journal-title":"Biometrika."},{"key":"key-201392481643-9","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.","volume":"295","author":"Kastrati A.","year":"2006","journal-title":"JAMA."},{"key":"key-201392481643-10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/ehm562","article-title":"One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.","volume":"29","author":"Ndrepepa G.","year":"2008","journal-title":"Eur Heart J."},{"key":"key-201392481643-11","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes.","volume":"355","author":"Stone GW.","year":"2006","journal-title":"N Engl J Med."},{"key":"key-201392481643-12","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction.","volume":"358","author":"Stone GW.","year":"2008","journal-title":"N Engl J Med."},{"key":"key-201392481643-13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.","volume":"359","author":"Kastrati A.","year":"2008","journal-title":"N Engl J Med."},{"key":"key-201392481643-14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000201273","article-title":"Patterns of presentation and outcomes of patients with acute coronary syndromes.","volume":"113","author":"Ndrepepa G.","year":"2009","journal-title":"Cardiology."},{"key":"key-201392481643-15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/eurheartj\/ehi002","article-title":"Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort.","volume":"26","author":"Terkelsen CJ.","year":"2005","journal-title":"Eur Heart J."},{"key":"key-201392481643-16","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).","volume":"32","author":"Hamm CW.","year":"2011","journal-title":"Eur Heart J."},{"key":"key-201392481643-17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00380-009-1205-7","article-title":"Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention.","volume":"25","author":"Ndrepepa G.","year":"2010","journal-title":"Heart Vessels."},{"key":"key-201392481643-18","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.","volume":"298","author":"Stone GW.","year":"2007","journal-title":"JAMA."},{"key":"key-201392481643-19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jacc.2008.05.036","article-title":"Safety and efficacy of bivalirudin with and without glycoprotein IIb\/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.","volume":"52","author":"White HD.","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-201392481643-20","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.","volume":"377","author":"Stone GW.","year":"2011","journal-title":"Lancet."},{"key":"key-201392481643-21","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1161\/CIRCULATIONAHA.108.787143","article-title":"Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.","volume":"118","author":"Wang TY.","year":"2008","journal-title":"Circulation."},{"key":"key-201392481643-22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/eurheartj\/ehn586","article-title":"Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.","volume":"30","author":"Iijima R.","year":"2009","journal-title":"Eur Heart J."},{"key":"key-201392481643-23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jacc.2012.02.044","article-title":"Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.","volume":"60","author":"Sibbing D.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201392481643-24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2009.06.021","article-title":"Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.","volume":"54","author":"Dangas G.","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-201392481643-25","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott SD.","year":"2007","journal-title":"N Engl J Med."},{"key":"key-201392481643-26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin L.","year":"2009","journal-title":"N Engl J Med."},{"key":"key-201392481643-27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.","volume":"115","author":"Grines CL.","year":"2007","journal-title":"Circulation."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T09:36:34Z","timestamp":1380015394000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/63rd_issue\/71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["20121217-03"],"URL":"https:\/\/doi.org\/10.4244\/eijv9i4a71","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}